The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30963178.
- Also identified by DOI 10.1093/cid/ciz288 and PMC identifier 6934254.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
From 2011 through 2016, we conducted surveillance for severe respiratory illness in infants. Human immunodeficiency virus exposure significantly increased the risk of respiratory syncytial virus (RSV)-associated hospitalization in infants aged <5 months. More than 60% of RSV-associated hospitalizations occurred in the first 4 months of life and may be preventable through maternal vaccination or birth-dose monoclonal antibody.
Medical subject headings
- Coinfection
- HIV Infections
- Respiratory Syncytial Virus Infections
- Respiratory Syncytial Virus, Human